摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[3-(3-bromopropoxy)-phenyl]-oxamic acid methyl ester | 103448-84-6

中文名称
——
中文别名
——
英文名称
N-[3-(3-bromopropoxy)-phenyl]-oxamic acid methyl ester
英文别名
methyl N-[3-(3-bromopropoxy)-phenyl]-oxamate;Methyl [3-(3-bromopropoxy)anilino](oxo)acetate;methyl 2-[3-(3-bromopropoxy)anilino]-2-oxoacetate
N-[3-(3-bromopropoxy)-phenyl]-oxamic acid methyl ester化学式
CAS
103448-84-6
化学式
C12H14BrNO4
mdl
——
分子量
316.151
InChiKey
ZMEHZNQZJHSJGN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.486±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    18
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    64.6
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    N-[3-(3-bromopropoxy)-phenyl]-oxamic acid methyl ester2,4-二羟基-3-丙基苯乙酮 在 potassium iodide 、 potassium carbonate 作用下, 以 丁酮 为溶剂, 生成 N-{3-[3-(4-acetyl-3-hydroxy-2-n-propylphenoxy)-propoxy]-phenyl}-oxamic acid methyl ester
    参考文献:
    名称:
    Novel resorcinol ethers and anti-inflammatory and anti-allergic use
    摘要:
    该公式的小说4-酰基邻苯二酚醚化合物,其中R.sub.1代表较低的烷基,R.sub.2代表较低的烷基,较低的烯基或较低的炔基,R.sub.3代表氢,较低的烷氧基,三氟甲基或卤素,alk代表烷基基团,其中R.sub.4,R.sub.5和R.sub.7中的一个基团是--NH--C(.dbd.O)--R.sub.8的基团,除了--NH--C(.dbd.O)--R.sub.8的基团是R.sub.9的基团和除了--NH--C(.dbd.O)--R.sub.8的基团是R.sub.10的基团之外,R.sub.6代表氢,较低的烷基,卤素,三氟甲基,可选地酯化或酰胺化的羧基,氰基或较低的烷酰基,R.sub.8代表可选地酯化或酰胺化的羧基,或5-四氮唑基,R.sub.9代表氢,较低的烷基,较低的烷氧基,卤素或三氟甲基,R.sub.10代表氢,较低的烷基,较低的烷氧基,卤素,三氟甲基,氰基或可选地酯化或酰胺化的羧基,它们的盐具有LTD.sub.4-拮抗和PLA.sub.2-磷脂酶抑制性能。它们可以根据已知方法制造。
    公开号:
    US04863942A1
  • 作为产物:
    描述:
    Oxalic acid monomethyl ester chloride 、 3-(3-溴-丙氧基)-苯胺吡啶二氯甲烷ethyl acetate dichloromethane 、 silica gel 、 hexane-diethyl ether 作用下, 以 二氯甲烷 为溶剂, 反应 2.17h, 以N-[3-(3-bromopropoxy)-phenyl]-oxamic acid methyl ester having a melting point of 90°-91° is obtained的产率得到N-[3-(3-bromopropoxy)-phenyl]-oxamic acid methyl ester
    参考文献:
    名称:
    Novel resorcinol ethers and anti-inflammatory and anti-allergic use
    摘要:
    式子为##STR1##的新型4-酰基间苯二酚醚,其中R.sub.1代表较低的烷基,R.sub.2代表较低的烷基,较低的烯基或较低的炔基,R.sub.3代表氢,较低的烷氧基,三氟甲基或卤素,alk代表烷基,R.sub.4、R.sub.5和R.sub.7中的一个是公式--NH--C(.dbd.O)--R.sub.8的基团,不是公式--NH--C(.dbd.O)--R.sub.8的基团R.sub.4或R.sub.5是基团R.sub.9,不是公式--NH--C(.dbd.O)--R.sub.8的基团R.sub.7是基团R.sub.10,R.sub.6代表氢,较低的烷基,卤素,三氟甲基,可选的酯化或酰胺化羧基,氰基或较低的烷酰基,R.sub.8代表可选的酯化或酰胺化羧基,或5-四唑基,R.sub.9代表氢,较低的烷基,较低的烷氧基,卤素或三氟甲基,R.sub.10代表氢,较低的烷基,较低的烷氧基,卤素,三氟甲基,氰基或可选的酯化或酰胺化羧基,以及它们的盐具有LTD.sub.4 -拮抗和PLA.sub.2 -磷脂酶抑制性能。它们可以根据已知的方法制造。
    公开号:
    US04863942A1
点击查看最新优质反应信息

文献信息

  • Novel fluorinated resorcinol ethers
    申请人:Ciba-Geigy Corporation
    公开号:US04670604A1
    公开(公告)日:1987-06-02
    4-Acylresorcinol ethers of the formula ##STR1## in which R.sub.1 is lower alkyl, R.sub.2 is fluorinated lower alkyl, R.sub.3 is hydrogen, lower alkoxy, trifluoromethyl or halogen, alk is an alkylene or hydroxyalkylene radical which is uninterrupted or interrupted by oxygen, one of the radicals R.sub.4, R.sub.5 and R.sub.7 is a group of the formula --NH--C(.dbd.O)--R.sub.8, a radical R.sub.4 or R.sub.5 which differs from this is a radical R.sub.9 and a radical R.sub.7 which differs from this is a radical R.sub.10, R.sub.6 is hydrogen, lower alkyl, trifluoromethyl, halogen, carboxyl which is free, esterified or amidated, cyano or lower alkanoyl, R.sub.8 is carboxyl which is free, esterified or amidated or 5-tetrazolyl, R.sub.9 is hydrogen, lower alkyl, lower alkoxy, halogen or trifluoromethyl and R.sub.10 is hydrogen, lower alkyl, lower alkoxy, halogen, trifluoromethyl, cyano or carboxyl which is free, esterified or amidated, and their salts have antiallergic and antiinflammatory properties. They are prepared, for example, by reacting compounds of the formulae ##STR2## in which one of the radicals X.sub.5 and X.sub.6 is hydroxyl which is free or in salt form and the other is an alkoxy radical substituted by reactive esterified hydroxyl or epoxy. The invention also relates to intermediates of the formula ##STR3## in which R.sub.2 is fluorinated lower alkyl, R.sub.3 is hydrogen, lower alkoxy, trifluoromethyl or halogen and R.sub.11 is hydrogen or a group of the formula R.sub.1 --O(.dbd.O)--, in which R.sub.1 is lower alkyl, and their salts.
    公式为##STR1##的4-酰基邻苯二酚醚中,其中R.sub.1为较低的烷基,R.sub.2为氟代较低的烷基,R.sub.3为氢、较低的烷氧基、三氟甲基或卤素,alk为未受氧或被氧中断的烷基或羟基烷基基团,R.sub.4、R.sub.5和R.sub.7中的一个是--NH--C(.dbd.O)--R.sub.8的基团,与此不同的基团R.sub.4或R.sub.5是基团R.sub.9,与此不同的基团R.sub.7是基团R.sub.10,R.sub.6为氢、较低的烷基、三氟甲基、卤素、游离的、酯化的或酰胺化的羧基、氰基或较低的烷酰基,R.sub.8为游离的、酯化的或酰胺化的羧基或5-四唑基,R.sub.9为氢、较低的烷基、较低的烷氧基、卤素或三氟甲基,R.sub.10为氢、较低的烷基、较低的烷氧基、卤素、三氟甲基、氰基或游离的、酯化的或酰胺化的羧基,以及它们的盐具有抗过敏和抗炎性能。例如,通过反应下列公式的化合物制备它们:##STR2##其中X.sub.5和X.sub.6中的一个是游离的或盐形式的羟基,另一个是被反应性酯化羟基或环氧基取代的烷氧基基团。该发明还涉及公式##STR3##中的中间体,其中R.sub.2为氟代较低的烷基,R.sub.3为氢、较低的烷氧基、三氟甲基或卤素,R.sub.11为氢或R.sub.1--O(.dbd.O)--的基团,其中R.sub.1为较低的烷基,以及它们的盐。
  • Oxaloamino substituted fluorinated resorcinol ethers and anti-allergic
    申请人:Ciba-Geigy Corporation
    公开号:US04820726A1
    公开(公告)日:1989-04-11
    4-Acylresorcinol esthers of the formula ##STR1## in which R.sub.1 is lower alkyl, R.sub.2 is fluorinated lower alkyl, R.sub.3 is hydrogen, lower alkoxy, trifluoromethyl or halogen, alk is an alkylene or hydroxyalkylene radical which is uninterrupted or interrupted by oxygen, one of the radicals R.sub.4, R.sub.5 and R.sub.7 is a group of the formula --NH--C(.dbd.O)--R.sub.8, a radical R.sub.4 or R.sub.5 which differs from this is a radical R.sub.9 and a radical R.sub.7 which differs from this is a radical R.sub.10, R.sub.6 is hydrogen, lower alkyl, trifluoromethyl, halogen, carboxyl which is free, esterified or amidated, cyano or lower alkanoyl, R.sub.8 is carboxyl which is free, esterified or amidated or 5-tetrazolyl, R.sub.9 is hydrogen, lower alkyl, lower alkoxy, halogen or trifluoromethyl and R.sub.10 is hydrogen, lower alkyl, lower alkoxy, halogen, trifluoromethyl, cyano or carboxyl which is free, esterified or amidated, and their salts have antiallergic and antiinflammatory properties. They are prepared, for example, by reacting compounds of the formulae ##STR2## in which one of the radicals X.sub.5 and X.sub.6 is hydroxyl which is free or in salt form and the other is an alkoxy radical substituted by reactive esterified hydroxy or epoxy. The invention also relates to intermediates of the formula ##STR3## in which R.sub.2 is fluorinated lower alkyl, R.sub.3 is hydrogen, lower alkoxy, trifluoromethyl or halogen and R.sub.11 is hydrogen or a group of the formula R.sub.1 --C(--O)--, in which R.sub.1 is lower alkyl, and their salts.
    公式为##STR1##的4-酰基邻苯二酚酯,其中R.sub.1为较低的烷基,R.sub.2为氟化的较低的烷基,R.sub.3为氢、较低的烷氧基、三氟甲基或卤素,alk为未被氧中断或中断的烷基或羟基烷基基团,R.sub.4、R.sub.5和R.sub.7中的一个是--NH--C(.dbd.O)--R.sub.8的基团,与此不同的基团R.sub.4或R.sub.5是基团R.sub.9,与此不同的基团R.sub.7是基团R.sub.10,R.sub.6为氢、较低的烷基、三氟甲基、卤素、游离的、酯化的或酰化的羧基、氰基或较低的烷酰基,R.sub.8为游离的、酯化的或酰化的羧基或5-四唑基,R.sub.9为氢、较低的烷基、较低的烷氧基、卤素或三氟甲基,R.sub.10为氢、较低的烷基、较低的烷氧基、卤素、三氟甲基、氰基或游离的、酯化的或酰化的羧基,它们的盐具有抗过敏和抗炎性能。例如,通过反应公式为##STR2##的化合物制备。其中,X.sub.5和X.sub.6中的一个是游离的或盐形式的羟基,另一个是被反应酯化的羟基或环氧基取代的烷氧基基团。本发明还涉及公式为##STR3##的中间体,其中R.sub.2为氟化的较低的烷基,R.sub.3为氢、较低的烷氧基、三氟甲基或卤素,R.sub.11为氢或R.sub.1--C(--O)--的基团,其中R.sub.1为较低的烷基,以及它们的盐。
  • Novel fluorinated resorcinol ethers and their use as anti-allergics and
    申请人:Ciba-Geigy Corporation
    公开号:US05032606A1
    公开(公告)日:1991-07-16
    4-Acylresorcinol ethers of the formula ##STR1## in which R.sub.1 is lower alkyl, R.sub.2 is fluorinated lower alkyl, R.sub.3 is hydrogen, lower alkoxy, trifluoromethyl or halogen, alk is an alkylene or hydroxyalkylene radical which is uninterrupted or interrupted by oxygen, one of the radicals R.sub.4, R.sub.5 and R.sub.7 is a group of the formula --NH--C(.dbd.O)--R.sub.8, a radical R.sub.4 or R.sub.5 which differs from this is a radical R.sub.9 and a radical R.sub.7 which differs from this is a radical R.sub.10, R.sub.6 is hydrogen, lower alkyl, trifluoromethyl, halogen, carboxyl which is free, esterified or amidated, cyano or lower alkanoyl, R.sub.8 is carboxyl which is free, esterified or amidated or 5-tetrazolyl, R.sub.9 is hydrogen, lower alkyl, lower alkoxy, halogen or trifluoromethyl and R.sub.10 is hydrogen, lower alkyl, lower alkoxy, halogen, trifluoromethyl, cyano or carboxyl which is free, esterified or amidated, and their salts have antiallergic and antiinflammatory properties.
    公式为##STR1##的4-酰基邻苯二酚醚,其中R.sub.1是低碳基,R.sub.2是氟化低碳基,R.sub.3是氢,低碳氧基,三氟甲基或卤素,alk是一个不间断或间断由氧原子组成的烷基或羟基烷基,R.sub.4,R.sub.5和R.sub.7中的一个是公式--NH--C(.dbd.O)--R.sub.8的基团,与此不同的基团R.sub.4或R.sub.5是基团R.sub.9,与此不同的基团R.sub.7是基团R.sub.10,R.sub.6是氢,低碳基,三氟甲基,卤素,自由的,酯化或酰胺化的羧基,氰基或低碳酰基,R.sub.8是自由的,酯化或酰胺化的羧基或5-四唑基,R.sub.9是氢,低碳基,低碳氧基,卤素或三氟甲基,R.sub.10是氢,低碳基,低碳氧基,卤素,三氟甲基,氰基或自由的,酯化或酰胺化的羧基,它们的盐具有抗过敏和抗炎性能。
  • US4670604A
    申请人:——
    公开号:US4670604A
    公开(公告)日:1987-06-02
  • US4820726A
    申请人:——
    公开号:US4820726A
    公开(公告)日:1989-04-11
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物